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Extrahepatic C6 is as effective as hepatic C6 in the generation of renal
C5b-9 complexes. In order to study the contribution of extrahepatic C6 to
anti-Thyl.1 nephritis, C6 deficient PVG/c— livers were grafted in C6
sufficient PVG/c+ rats (Tx-L). Infusion of anti-Thyl.1 antibodies in Tx-L
and PVG/c+ rats resulted in generation of C5b-9 complexes and subse-
quent glomerular injury, while infusion of anti-Thyl.1 antibodies in
PVG/c— rats revealed no detectable C6 deposition. Because C6 mRNA
was expressed in both liver and kidney tissue of PVG/c+ rats, we assessed
whether production of C6 in the kidney alone was sufficient for glomerular
injury. One kidney of a PVG/c— rat was replaced with a PVG!c+ kidney
(Tx+K) followed by administration of anti-Thyl.1 antibodies. C6 deposits
were detectable neither in PVG/c+ kidneys nor in PVG/c— kidneys of
Tx+K rats, indicating that C6 production in PVGIc+ kidneys alone is not
sufficient to contribute to renal injury. That C6 production had occurred
was suggested by the presence of equal amounts C6 mRNA in control
PVG/c+ kidneys and in grafted PVG/c+ kidneys of Tx+ K rats. C6 mRNA
expression in kidney tissue of PVG/c+ rats is presumably derived from
peritubular sites. In conclusion, we have demonstrated that extrahepatic,
but not renal synthesis of, C6 is sufficient to contribute to glomerular
injury during anti-Thyl.I nephritis.
The complement system consists of at least 20 plasma proteins
with inflammatory and immune regulatory functions. The main
source of circulating complement is the liver [1—3], but extrahe-
patic synthesis of complement is found in, for instance, brain [4],
skin [5] and synovial tissue [6]. Extrahepatic synthesis of comple-
ment also occurs in the kidney. In two inbred mice strains with a
spontaneous development of systemic lupus erythematosus(SLE), an increase in C3, C2 and C4 mRNA expression was
observed in nephritic kidneys as compared to the expression in
control kidneys [7, 8]. C3 mRNA expression in kidneys of patients
with immune complex glomerulonephritis was higher than the
expression of C3 in kidneys of normal individuals [9]. In renal
transplantation patients having differences in C3 allotypes, it was
shown by RT-PCR analysis that C3 mRNA detected in the kidney
was derived from intrinsic renal cells and not from infiltrating cells
of donor origin [10].
A number of complement deficient animals are available to
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study the production of complement components at extrahepatic
sites [11]. Recently, a rat strain was described with a total
deficiency for C6 and a partial deficiency for C2 (PVG/c—) [12,
13]. By performing transplantations of a PVG/c— liver to a
complement sufficient rat (PVGIc+) it was demonstrated that the
relative contribution of extrahepatic C6 to circulating levels of C6
is about 25% [14] (Timmerman et al, unpublished data). Further-
more, these rat strains were used to show that C6 is important for
the progression of disease. Brandt et al [13] induced membrano-
proliferative glomerulonephritis in PVGIc— and PVGIc+ rats by
infusion of anti-thymocyte serum. While C5b-9 antigens were
detectable in glomeruli of PVG/c+ rats, these C5b-9 deposits
were not observed in the glomeruli of PVG/c— rats or comple-
ment depleted PVG/c+ rats. Similar results were obtained in a
study in which membranous nephropathy was induced in Sprague
Dawley rats with or without circulating C6 [15]. Glomerular
deposition of IgG and C3 was similar in both groups, but
glomerular CSb-9 and proteinuria were absent in the C6-depleted
rats. These experiments stress the importance of C6 in the
progression of renal disease.
In the present study we used two transplantation models to
investigate the role of extrahepatically or renally synthesized C6
during experimental Thyl.1 nephritis. In one model, C6-deficient
livers were transplanted to sufficient rats (Tx-L: rats with only
extrahepatic synthesis of C6) to investigate the contribution of
extrahepatically synthesized C6 to glomerular injury. In another
model, C6-sufficient kidneys were transplanted to deficient rats
(Tx+K: rats with only synthesis of C6 in the grafted kidney) to
investigate the contribution of C6 synthesized by intrinsic renal
cells to nephritis. It was found that extrahepatic synthesis of C6
was efficient in the generation of C5b-9 complexes and subsequent
glomerular damage, while local synthesis of C6 in the kidney was
not sufficient to support the generation of C5b-9 complexes.
Methods
Reagents
Sheep erythrocytes (Biotrading, Mijdrecht, The Netherlands),
DIG (digoxigenin)-NHS and sh-Fab' anti-DIG-HRP (Boehringer
Mannheim, Mannheim, Germany), a-[32PIdCTP (Amersham, Ar-
lington Heights, IL, USA), reinforced nitrocellulose (Schleicher
and Schuell, Dassel, Germany) and tyramide-fluos (NEN-Du-
Pont, Boston, MA, USA) were obtained as indicated. Mouse
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monoclonal anti-rat macrophage!monocyte antibody (ED1) was
provided by Dr. C.D. Dijkstra (Free University of Amsterdam,
Amsterdam, The Netherlands), monoclonal antibody mouse anti-
rat C6 was a gift from Dr. W.G. Couser (University of Washing-
ton, Seattle, WA, USA). Human C6 eDNA probe was provided by
Dr. DiScipio (La Jolla Institute for Experimental Medicine, La
Jolla, CA, USA). Glyceraidehyde 3-phosphate (GAPDH) cDNA
was obtained from the American Type Culture Collection
(ATCC, Rockville, MD, USA).
Experimental animals
Three-month-old complement deficient PVG/c rats (PVG/c—)
(Bantin and Kingman, Edmonds, UK) and complement sufficient
PVG/c rats (PVG/c+) (Harlan Sprague Dawley, Cambridge,
UK), weighing 200 to 300 grams were used for the experiments.
The rats were housed in an accredited animal breeding facility
with free access to normal rat chow and water.
Liver and kidney transplantation
Liver transplantations were performed as described [161. After
transplantation, blood samples were obtained by tail bleeding on
days 1, 2, 4, 6, 8, 11, 14, 21, 28, 35 and 42. The sera were tested by
hemoiytic assays for C2, C3, C6 and CH5O and in a specific rat C6
ELISA.
Kidney transplantations were performed as reported previously
[17, 181. Briefly, the aorta, vena cava and ureter of the right kidney
were dissected and the organ was perfused with University of
Wisconsin solution and kept on ice. The vena cava and the aorta
in the recipient were dissected below the renal vessels and ligated
with the donor aorta and vena cava. The tip of the donor-ureter
was drawn into the bladder via a small incision in the fundus of the
bladder. Blood samples were obtained at several time points after
transplantation.
Induction of anti-Thyl. 1 nephritis
Transient Thyl.1 nephritis [19, 20] was induced in male rats by
a single intravenous injection with IgG2a anti-Thyl.1 mouse
monoclonal antibodies (ER4G, 1 mg/kg body wt). In this study
four experimental groups with three rats each were used: (1)
PVG/c— rats, (2) PVG/c+ rats, (3) PVG/c+ rats with a PVG/c—
liver (Tx-L) and (4) PVG/c— rats with one PVG/c+ kidney and
one PVG/c— kidney (Tx+K). Circulating complement levels in
Tx-L and Tx+K rats were determined six weeks after transplan-
tation. The monoclonal antibodies were purified from ascitic fluid
as described previously [19]. Control rats were infused with the
same volume phosphate buffered saline (PBS). Blood samples
were obtained by tail bleeding immediately before induction of
nephritis and 2, 8, 24 hours, and four and six days after induction
to determine hemolytic activity. Urine samples were obtained on
the day (day —1) before the infusion of ER4G and on the day
thereafter (day 1) to determine albuminuria. On day —1 and day
1 kidney cortex and liver biopsies were obtained and snap-frozen
immediately. The biopsies were used for periodic acid-Schiff
(PAS) and hematoxylin-eosin (HE) staining and for immunoflu-
orescence studies. On day 1 kidney cortex and liver tissue was
isolated, snap-frozen and stored in liquid nitrogen for RNA
isolation.
Hemolytic assays
Hemolytic assays for C3, CH5O [21] and C2 [13] were per-
formed as described previously. Hemolytic activity of C6 was
assessed using EA (sheep red blood cells sensitized with subag-
glutinating amounts of rabbit IgG anti-sheep erythrocytes) and
C6-deficient human serum. Briefly, rat serum samples were
diluted in DGVB (half-isotonic Veronal buffered saline con-
taining 0.05% gelatin, 0.15 mrvi CaCl2 + 0.5 mM MgCI2 and 3%
dextrose) and 100 itl was incubated with 100 sl EA in DGVB
(108 cells/mi) containing a 1/100 dilution of C6 deficient human
serum for 60 minutes at 37°C. The samples were centrifuged for
10 minutes at 2,000 rpm and hemolysis was measured in the
supernatants with a Beckman photospectrometer at absorbance of
414 nm. The number of effective hemolytic sites generated (Z)
was calculated and expressed as percentage consumption of
complement relative to hemolytic activity in PVG/c+ serum
before transplantation. The consumption in PVG/c+ serum was
assigned the value of 100%.
Immunofluorescence studies
Frozen sections of 4 tm were mounted on glass slides, air-dried
for 60 minutes and fixed for 10 minutes with water-free acetone at
room temperature. After washing with PBS, the sections were
incubated with specific antibodies in PBS-1% bovine serum
albumin (BSA). For the detection of mouse IgG2a (ER4G), rat
C3 and monocytes fluorescein isothiocyanate (FITC)-conjugated
goat anti-mouse IgG2a (F/P ratio 2, 1 mg/mi), FITC conjugated
rabbit anti-rat C3 (F/P ratio 2.6, 5 mg/mi) and mouse monoclonal
anti-rat monocyte/macrophage (F/P ratio 3.3, 1.3 mg/mi) were
used, respectively. For the staining of rat C6 an enhanced staining
method was used [22]: incubation with DIG-conjugated mouse
anti-rat C6 in PBS-BSA was followed by incubation with HRP-
conjugated sh-Fab' anti-DIG antibodies and tyramide-fluos. Pho-
tographs were taken on Kodak TX-400 films on a Leitz micro-
scope equipped with a 4-mm BG38 + 5-mm BG12 filter for FITC.
Immunodiffusion
Urinary excretion of rat albumin was determined by rocket-
eiectrophoresis using rabbit anti-rat serum albumin (RSA). Anti-
RSA was diluted 1/50 in a 2% agarose solution. Subsequently,
agarose gels were poured onto slides and allowed to set. Wells
were punched in the agarose and filled with undiluted urine
samples and filled with dilutions of RSA as a standard. The
samples were subjected to electrophoresis for five hours at 40 mA
and rinsed in PBS containing 2 mr'i EDTA. Precipitation arcs were
visualized with Commassie brilliant blue and rocket heights were
compared to the RSA standard.
Northern blot and dot blot analysis
Total RNA from liver tissue was isolated and purified as
described previously [23]. Forty micrograms of total RNA and
three-fold serial dilutions were spotted on a nitrocetlulose filter
using a Bio-dot apparatus [24]. The filter was hybridized under
high stringent conditions [24]. The cDNA probes were radiola-
beled with [32P] by random priming labeling [25]. The probes used
were a 490 bp rat C6 cDNA fragment and finally a 1300 bp EcoRi
GAPDH eDNA fragment to quantify the amount of RNA loaded
per lane. The 490 bp rat C6 cDNA clone was cloned, using human
C6 eDNA, from a rat liver cDNA library in AgtlO (RLIO2Oa from
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Table 1. Percentage of hemolytic activity in sera of PVG/c— and Tx-L
rats as compared to the hcmolytic activity in serum of PVG/c+ rats
Hemolytic activity PVG/c+ PVG/c— TxLa
CH5O 100 NDh 13 5
C6 100 ND" 23±4
C2 100 5±4 22±9
C3 100 97±15 97±13
a Serum obtained six weeks after transplantation
"ND, not detectable
Clonetech Laboratories, Palo Alto, CA, USA). The sequence of
the 490 bp of the rat C6 eDNA was determined by dideoxyse-
quencing and sequence analysis was performed using Geneworks
(IntelliGenetics Inc., Mountain View, CA, USA). Rat C6 was
found to be homologous to human C6 at the DNA and deduced
protein level (van Dixhoorn et al, unpublished data).
RT-PCR analysis
Total cellular RNA was isolated from snap frozen tissues using
the LiCl-ureum precipitation method as described previously [23].
mRNA was reverse transcribed into eDNA and PCR was per-
formed as described previously [23, 24]. Briefly, eDNA was
amplified in 33 cycles, each consisting of 2.5 minutes at 95°C, 1.5
minutes at 55°C and 1.0 minute at 72°C. The sequences of the
oligonucleotide primers were: 5' TGC CTC AAA CCA GTC
OTT 3' sense and 5' GCA GAT GAA GTG AAG TAC TGA 3'
anti-sense for rat C6 and 5' CTA CAA TGA GCT GCG TGT GG
3' sense and 5' AAG GAA GGC TGG AAG AGT GC 3'
anti-sense for f3-actin [26]. The length of the amplicons for rat C6
and 13-actin were 334 bp and 527 bp, respectively.
Statistical analysis
Statistical analysis was performed using the Student's t-test for
unpaired samples. A P value of 0.05 was used to determine
significance.
Results
Transplantation of a PVG/c — liver to a PVG/c + rat
First, it was investigated whether the amount of extrahepatically
synthesized C6 was sufficient to contribute to renal injury during
acute anti-Thyl.1 nephritis. PVG/c+ rats were grafted with a
PVG/c— liver (Tx-L) to investigate the extrahepatic synthesis of
C6 (Timmerman et al, unpublished data). Previously it was
demonstrated that transplantation between the PVG/c— and
PVG/c+ rat strain is possible without rejection [121. Hemolytic
activity in serum of Tx-L rats obtained six weeks after transplan-
tation was compared to hemolytic activity in control PVG/c— and
PVG/c+ rats (Table 1). While the hemolytic activity of C3 was
similar in the three groups, CH5O, C6 and C2 activities in Tx-L
rats were lower than the activity detected in PVG!c+ rats and
higher than the levels in PVG/c— rats. The circulating Co levels in
Tx-L rats were 25% of the levels found normally in PVG/c+ rats.
Induction of anti- Thy]. 1 nephritis
PVG/c—, PVG/c+ and Tx-L rats were injected i.v. with ER4G
(1 mg/kg body wt) and kidney biopsies were obtained 24 hours
thereafter and assessed for the presence of ER4G (mouse IgG2a),
rat C3 and rat C6. Strong mesangial staining for mouse IgG2a and
rat C3 was observed in glomeruli of PVGIc—, PVG/c+ and Tx-L
rats injected with ER4G (Figs. 1 and 2), suggesting that comple-
ment activation was comparable in these rats. Mesangial staining
for mouse IgG2a and rat C3 was not detectable in control
PVG/c+, PVG/c— and Tx-L rats infused with PBS alone.
Mesangial C6 deposits were found in glomeruli of PVG/c+ and
Tx-L rats infused with ER4G and not in PVG/c— rats receiving
ER4G (Fig. 3). In PVG/c+, PVG/c— and Tx-L rats infused with
PBS alone no glomerular C6 deposits were seen. Mesangial C5b-9
deposits were also detected in glomeruli of PVG/c+ and Tx-L rats
infused with ER4G (results not shown). Furthermore, kidneys of
PVG/c+ rats could be distinguished easily from kidneys of
PVG/c— rats by the peritubular staining for C6 in PVG/c+
kidneys. A similar staining pattern for C3 was found in kidneys of
rats infused with PBS alone (Fig. 2D). This peritubular staining
pattern for C3 and C6 is a normal feature in kidneys of PVG/c+
and Wistar rats.
Markers of inflammation during Thy].] nephritis
We also investigated whether C6 deposition in Tx-L rats (with
only extrahepatic C6 synthesis) was associated with inflammation
as assessed by albuminuria and influx of inflammatory cells.
Albuminuria was assessed by rocket electrophoresis of urine
collected on day — 1 and day 1 after infusion of ER4G. The
albuminuria on day —1 was 0.40 0.06, 0.72 0.15 and 0.42
0.06 mg mg124 hr for PVGIc+, PVG/c— and Tx-L rats, respec-
tively. On day 1 after ER4G administration a significant increase
in albumin excretion was observed of 1.56 0.31 mg124 hr for the
PVG/c+ rat (P < 0.05) and the albumin excretion in Tx-L rats on
day 1 was 1.79 1.6 mg/24 hr (Fig. 4A). The albumin excretion of
0.61 0.21 mg/24 hr for PVG/c— rats was not altered significantly
following administration of ER4G.
Furthermore, the influx of macrophages/monocytes was as-
sessed on day —1 and day 1 after infusion of ER4G. The mean
number of ED1 positive (EDI +) cells in glomeruli of PVG/c+,
PVG/c— and Tx-L rats on day —1 was 1.29 1.27, 1.12 1.10
and 0.90 0.77 EDI + cells/glomerulus, respectively. In glomeruli
of PVG/c— rats the number of EDI + cells of 0.71 0.78 was not
significantly altered after ER4G administration, while a significant
increase (P < 0.05) in EDI + cells/glomerulus of 6.15 2.89 and
5.05 1.95, respectively, was observed in glomeruli of PVG/c+
and Tx-L rats (Fig. 4B).
In addition to albuminuria and influx of monocytes we also
assessed the mesangiolysis on day 1 as a hallmark of complement
dependent glomerular damage. It was found that both PVG/c+
and Tx-L kidneys had prominent lesions in the mesangial area of
the glomerulus after administration of anti-Thyl.1 antibodies
(results not shown). In PVG/c— kidneys these lesions were not
observed.
C6 mRNA expression in liver and kidney
We showed previously that rat C6 mRNA wit a size of 3.3 kb is
expressed in PVG/c— livers, while C6 antigens were not detect-
able in PVG/c— serum (van Dixhoorn et al, unpublished data). To
investigate the hepatic expression of C6 mRNA was isolated from
control PVG/c+, PVO/c— and Tx-L livers and from livers ob-
tained 24 hours after infusion of ER4G. Dot blot analysis revealed
that the C6 mRNA expression in PVG/c+ livers was higher than
C6 mRNA expression in livers of PVG/c— and Tx-L rats (Fig. 5).
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Fig. 1. Immunofluorescence staining for ER4G
in PVG/c— (A), PVG/c+ (B) and Tx-L rats (C).
(D) A kidney section of a PVG/c+ rat infused
with PBS. The other rats were infused with
ER4G (mouse IgG2a) and kidney biopsies were
obtained on day 1 after ER4G infusion. The
sections were incubated with goat anti-mouse-
FITC for the presence of ER4G.
Fig. 2. Immunofluorescence staining for C3 in
PVG/c— (A), PVG/c+ (B) and Tx-L rats (C).(D) A kidney section of a PVG!c+ rat infused
with PBS. The other rats were infused with
ER4G and kidney biopsies were obtained on
day 1 after ER4G infusion. The sections were
incubated with rabbit anti-C3-FITC for the
presence of C3.
There was no difference in hepatic CO mRNA expression after PVG/c— and Tx-L rats to investigate whether C6 mRNA is
infusion of ER4G antibodies. expressed in kidney tissue of these rats. With a sensitive RT-PCR
Messenger RNA was isolated from kidneys of PVG/c+, technique it was possible to detect CO mRNA expression in
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Fig. 3. Immunofluorescence staining for C6 in PVG/c— (A), PVG/c+ (B) and Tx-L rats (C) infused with PBS and in PVG/c— (D), PVG/c+ (E) and Tx-L
rats (F) infused with ER4G. The rats were infused with PBS or ER4G and kidney biopsies were obtained on day 1 after infusion. The sections were
incubated with mouse anti-C6-DIG followed by incubation with anti-DIG-HRP and tyramide-fluos for the presence of C6.
Fig. 4. Albuminuria (A) and influx of
inflammatoiy cells (B) in PVG/c+, PVG/c— and
Tx-L rats. Rats were infused with ER4G
antibodies and on day —1 () and day 1 (iii)
urinary albumin secretion was determined by
immunodiffusion. The number of ED1+ cells
per glomerulus was determined on day —1 and
day 1, and is expressed as mean macrophage
number SD per glomerulus.
kidneys of PVG/c+ and Tx-L rats (Fig. 6). C6 mRNA was also
expressed in PVG/c— kidneys although to a lesser extent,
Transplantation of a PVG/c+ kidney to a P1/Gte— rat
Because C6 mRNA is expressed in kidneys we investigated
whether synthesis of C6 in the kidney alone in a C6-negative
environment would support an anti-Thyl.1 mediated injuly of the
kidney. Therefore, one kidney of a C6-deficient PVG/c— rat was
replaced with one C6-sufficient PVGIc+ kidney (Tx+K). In the
circulation of the Tx+K rats neither C6 hemolytic activity nor C6
antigens were detectable after transplantation, indicating that
local synthesis of C6 in the kidney is not sufficient for an increase
of circulating levels of C6. ER4G antibodies were infused in
Tx+K rats, and 24 hours thereafter kidney biopsies were assessed
for the presence of mouse IgG2a and rat C3. In glomeruli of both
PVG/c— and PVGIc+ kidneys of Tx+K rats a mesangial staining
for lgG2a and C3 was observed (Figs. 7 and 8). Mesangial
deposits of C6, however, were found neither in PVGIe— kidneys
nor in PVG/c+ kidneys of Tx+K rats (Fig. 9), while mesangial
staining for C6 was present in glomeruli of PVG/c+ rats infused
with ER4G at the same time. In PVG/c+ and PVG!c— kidneys of
Tx+K rats C5b-9 complexes were also not detectable after
infusion of ER4G (results not shown). The grafted PVG/c+
kidney of the Tx+K rat can be distinguished from the PVGIc—
kidney by the pcritubular staining for C6. When the influx of
ED1+ cells was assessed in the PVG/c— and the PVG/c+ kidney
of Tx+K rats no increase was detected in the number of ED1+
cells after the infusion of ER4G antibodies.
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PBS
ER4
PBS
Rat C6 3-actin
1 2 3 1 2 3
3-actin
Rat C6
1 2 3 4 M
Fig. 6. RT-PCR analysis for the presence of rat CO mRNA in kidneys of
PVG/c—, PVG/c+ and Tx-L rats. mRNA isolated from kidneys of (lane 1)
PVG/c—, (lane 2) PVG/c+ and (lane 3) Tx-L rats was reverse transcribed
into eDNA and RT-PCR analysis was performed with specific primers for
13-actin and rat C6. In lane 4 the H20 control is shown and the 600 bp band
of a 100 bp-ladder is marked.
Fig. 5. Dot blot analysis for the presence of rat C6 mRNA in livers of
PVC/c—, PVG/c+ and Tx-L rats. mRNA was isolated from livers of
PVG/c—, PVG/c-1- and Tx-L rats 24 hours after infusion of PBS or after
infusion with ER4G. RNA was spotted in threefold serial dilutions on a
nitrocellulose filter and the blot was subsequently hybridized with specific
eDNA probes for rat C6 and 13-actin.
Tx+K rats were repeatedly injected with ER4G (2 mg/kg body
wt on days 1 and 10) [27] to investigate whether C6 synthesis in
the kidney was induced during a more chronic stimulation. Kidney
biopsies of PVG/c— and PVG/c+ kidneys of Tx+K rats were
obtained on days 5 and 20 after infusion of ER4G. Again, IgG2a
and C3 were detected in the mesangial area of both the PVG/c—
and PVG/c+ kidney of the Tx+K rat while C6 antigens were only
detected in the peritubular region of the PVG/c+ kidney (results
not shown).
CO mRNA expression in kidneys of Tx+K rats
To investigate whether C6 mRNA was expressed in both
kidneys mRNA was isolated from both PVG/c— and PVG/c+
kidneys of Tx+K rats and assessed for C6 mRNA expression. It
was found that C6 mRNA was expressed in grafted PVG/c+
kidneys to the same extent as in normal PVG/c+ kidneys. On the
other hand, the expression of C6 in PVG/c— kidneys of Tx+K rats
was low and comparable to that in normal PVG/c— kidneys (Fig.
10). Thus, C6 mRNA expression in the grafted PVG/c+ kidney
was not altered after transplantation.
Discussion
In glomeruli of rats infused with anti-Thyl.1 antibodies deposits
of both C3 and C5h-9 are observed in combination with an influx
of platelets and monocytes [19, 201. Although anti-Thyl.1 nephri-
tis is a severe model for human forms of glomerulonephritis, we
used this model in our study because of the prominent mesangial
deposits of complement proteins. That C6 is important for the
progression of glomerular injury was demonstrated previously in a
rat model of experimental membranous nephropathy. It was
found that C6 is essential for the development of proteinuria [15].
The role of C6 in mediating experimental mesangioproliferative
glomerulonephritis (MPGN) was studied using the C6 deficient
PVG/c— rat strain and the syngeneic PVG/c+ control strain [13].
Anti-thymocytc serum (ATS) was infused in PVG/c— and
PVG/c+ rats to induce nephritis. A marked difference in protein-
uria, macrophage and platelet influx, and glomerular cell prolif-
eration was observed in PVG/c— rats as compared to PVG/c+
rats. In addition, no C5b-9 deposits were detected in glomeruli of
PVG/c— rats.
In the present study we investigated whether extrahepatic
synthesis of complement C6 is sufficient to induce complement-
mediated injury during anti-Thyl.1 nephritis. PVG/c— livers were
grafted in PVG/c+ rats (Tx-L) to generate rats with extrahepatic
synthesis of C6 alone. We and others reported previously that
circulating levels of C6 in Tx-L rats are approximately 25% of the
levels observed in normal PVG/c+ rats [14]. Brauer et al [28] have
demonstrated that extrahepatically produced C6 contributes to
hyperacute rejection. Rejection of grafted guinea pig hearts in
PVG/c+ rats and in rats with extrahepatic synthesis of C6
occurred within approximately 0.6 hours, while guinea pig hearts
in PVG/c— rats survived for more than 45 hours. These results
indicate that extrahepatically synthesized C6 induces rejection to
the same extent as C6 synthesized by the liver. We found that
extrahepatically synthesized C6 was as effective as C6 synthesized
by the liver in its ability to induce glomerular damage following
administration of anti-Thyl.1 antibodies (Figs. 3 and 4). In our
study only the events of the acute phase of anti-Thyl.l nephritis
were investigated because complement activation and subsequent
deposition occur almost immediately following infusion of anti-
Thyl.1. In this phase of anti-Thyl.1 nephritis, we would also
expect an induction of the local production of complement.
An increase in macrophage influx in glomeruli of PVG/c+ and
Tx-L rats was observed after infusion of ER4G (Fig. 4B), which is
in agreement with earlier findings in PVG/c+ rats receiving
anti-thymocyte globulin (ATG) [13]. In contrast, no increase in
glomerular macrophage number was observed in PVG/c— rats
receiving either ER4G or ATG. Although these PVG/c— rats
have decreased levels of C2 and CS, it was observed that equal
amounts of C3d and C5a were generated in these rats [13].
Therefore, it is assumed that C5a is not the major agent respon-
sible for the rnacrophage influx in glomeruli of PVG/c+ rats.
Complement depletion with CVF in PVG/c+ rats also resulted in
a decrease in influx of macrophages. Therefore, the increase in
macrophage number might be the result of an increased expres-
sion of chemokines induced by activation of complement. Stahl et
al [29] reported an increased expression of MCP-I in combination
with an influx of macrophages in kidneys of Wistar rats infused
with ATG. When these rats were depleted of complement with
ER4
PBS
ER4
S..
• S..S.. S..
... S..S..0.
1794 Timmerman et al: Extrahepatic C6 and renal C5b-9
Fig. 7. Immunofluorescence staining for ER4G in PVG/c— (A) and PVG/c+ (B) kidneys of Tx+K rats. The rats were infused with ER4G (mouse IgG2a)
and kidney biopsies were obtained on day 1 after ER4G infusion. The sections were incubated with goat anti-mouse-FITC for the presence of ER4G.
Fig. 8. Im.nunofluorescence staining for C3 in Pi/G/c— (A) and PVG/c+ (B) kidneys of a Tx+K rats. The rats were infused with ER4G and kidney
biopsies were obtained on day 1 after ER4G infusion. The sections were incubated with rabbit anti-C3-FITC for the presence of C3.
cobra venom factor (CVF), administration of ATG did not result expressed in the kidney. By in situ hybridization, mRNA expres-
in an increased expression of MCP-1. Thus, sublytic C5b-9 sion for C4, C3 and factor B has been detected in tubuli [30, 311,
activation of mesangial cells may result in increased production of and C3 mRNA expression was also found in glomeruli [321.The
chemokines such as MCP-1 and subsequent induction of macro- expression of complement components was found to be increased
phage influx, in nephritic kidneys in a murine model of lupus nephritis [8].
In this study we found that rat C6 mRNA is not only expressed Furthermore, the synthesis of components such as C3, C4 and
in the liver but also in the kidney (Figs. 5 and 6). In addition, it has factor B [24, 33] by mesangial cells in vitrowas regulated by
been shown by others that a number of complement genes are cytokines. To investigate whether local synthesis of C6 in the
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Fig. 9. Immunofluorescence staining fbr C6 in PVGIc— (A) and PVG/c+ (B) kidneys of PBS-infused Tx+K rats and in PYGIc— (D) and a PVG/c+ (E)
kidneys of ER4G-infused Tx+K rats. The rats were infused with PBS or ER4G and kidney biopsies were obtained on day 1. The sections were incubated
with mouse anti-C6-DIG followed by incubation with anti-DIG-HRP and tyramidc-fluos for the presence of C6. As a control kidney sections of PVG/c+
rats infused with PBS (C) or ER4G (F) at the same time were also stained for C6.
Rat 06
1 2 3 4 5 6 7 M
kidney was sufficient to generate C5b-9 complexes, ER4G anti-
bodies were infused in PVG/c— rats grafted with a PVG/c+
kidney (Tx+K). Mesangial C6 deposits were not detected in
PVG/c+ kidneys and PVG/c— kidneys of Tx+K rats. That
complement activation had occurred was shown by the presence
of C3 deposits (Figs. 8 and 9). Even though mRNA for C6 was
expressed in the transplanted PVGI+ kidneys and immunohisto-
chemical staining for C6 was present at peritubular sites, no C5b-9
generation had occurred in these PVG/c+ kidneys. One possibil-
ity is that the amount of C6 produced in the kidney is not sufficient
to result in C5h-9 generation. In retrospect, another possible
explanation might be that C6 synthesized at peritubular sites does
not reach the mesangial area. Therefore, we are planning studies,
using experimental models for tubular or interstitial nephritis, to
elucidate the role of C6 synthesized at peritubular sites in the
kidney. In these studies we hope to find evidence whether or not
locally synthesized C6 contributes to an experimental model for
nephritis.
In conclusion, this study shows that extrahepatically synthesized
Fig. 10. RT-PCR analysis for the presence of rat
C6 mRNA in kidneys of Tx+K PVG/c--, and
PVG/c+ rats. mRNA isolated from PVG/c—
(lanes I and 3) and PVG/c+ (lanes 2 and 4)
kidneys of Tx+K rats and mRNA isolated from
kidneys of control (lane 5) PVG/c— and (lane
6) PVG/c+ rats was reverse transcribed into
cDNA and RT-PCR analysis was performed
with specific primers for rat C6. In lane 7 the
H70 control is shown and the 600 bp band of a
100 bp-ladder is marked.
C6 is as efficient as hepatic C6 in the generation of C5b-9
complexes during an anti-Thyl.1 induced nephritis. Furthermore,
we have demonstrated that local synthesis of C6 at peritubular
sites in the kidney is not sufficient to contribute to glomerulone-
phritis. It is, however, possible that local synthesis of other
complement proteins in the kidney may play an essential role
during the progression of disease. The availability of complement
knockout mice for C3, C4 [34] and factor B [35] and their
syngeneic controls makes it possible to investigate the local
production of complement in an appropriate fashion.
Reprint requests to Janneke J. Timmerman, Ph.D., Department of Nephrol-
ogy, University Hospital Leiden, Building 1, C3P, P0-Box 9600, 2300 RC
Leiden, The Netherlands.
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